NATUREX : 2010 Reference Document available


Avignon, May 2nd, 2011 - Naturex, the world leader in speciality plant-based natural ingredients, has published its reference document for the year ended December 31st, 2010.

o   2010 Reference Document

The 2010 reference document was registered with the Autorité des Marchés Financiers (AMF) on April 28th, 2011 under n°D.11-0389.

This document includes :

the annual financial report for the year ended December 31st, 2010 according to article L 451-1-2 of Code monétaire et financier ; the Chairman of the Board of Directors' Report on Corporate Governance, internal control and risk management ; the information related to the Statutory Auditors'fees ; the annual information document ; the resolutions proposed by the Board of Directors for the Ordinary and Extraordinary General Meeting of June 27th, 2011, for which the notice will be published in the Bulletin d'Annonces Légales et Officielles (BALO) within the legal time limits.

This document is available in French on the Company's website, in the « Investors » section, as well as on
English translation of this document will be soon available.

Copies of the reference document are also available in French, free of charge and on simple request with the Company.

o   Next publications and events

1st Q results, 2011 : May 30, 2011 AGM : June 27, 2011

Receive free of charge by e-mail all financial information concerning NATUREX by registering on:

NATUREX has been listed on segment B of NYSE Euronext Paris since October 1996

Number of shares in the capital: 6,410,931
o     4,959,935 ordinary shares (ISIN FR0000054694)
o     1,450,996 preferred shares (ISIN FR0000010833251)

Naturex is part of the CAC Small and Gaïa Indexes.
Naturex is eligible for the "long-only" DSS.

MNEMO: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP

About Naturex
Naturex is the global leader in specialty plant-based natural ingredients.
The Group is organised around three strategic markets - Food & Beverage, Nutrition & Health and Personal Care - and produces and markets specialty plant-based natural ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
Naturex's head office is based in Avignon. The company employs more than 950 people and has high-performance industrial resources through its 11 industrial sites in Europe (France, Italy, Spain, the United Kingdom and Switzerland), as well as in Morocco, the United States, Brazil and Australia. It also benefits from sales presence around the world through a dedicated network of sales offices in 19 countries (France, Italy, Spain, the United Kingdom, Belgium, Germany, Switzerland, Russia, U.A.E., Thailand, Singapore, Japan, China, Korea, Australia, the United States, Canada, Brazil and Mexico).
Naturex's sound performance is linked to the fast-growing demand for natural products and its capacity to provide manufacturers with the personalised means to meet the requirements of their end consumers. The Group's strength lies in its positioning on specific products which constitute niche markets, thanks to strong sourcing capacity and sustained Research & Development.

o   Naturex Contacts
Jacques Dikansky
President and CEO
Tel.: +33 (0)4 90 23 96 89 
Thierry Lambert
Vice-President and CFO
Tel.: +33 (0)4 90 23 96 89
Carole Alexandre
Investor Relations
Tel.: +33 (0)4 90 23 78 28

o   Actus Finance contacts
Anne Catherine Bonjour
Actus Press Relations
Tel.: +33 (0)1 53 67 36 93
Jérôme Fabreguettes-Leib
Investor Relations
Tel.: +33 (0)1 77 35 04 36
Information réglementée
Communiqués de mise à disposition de documents :
- Modalités de mise à disposition de document de référence ou de ses actualisations Communiqué intégral et original au format PDF : © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur
Receive by email the next press releases of the company by registering on, it's free

Valeur associée
  Libellé Bourse Dernier Var. Vol.
Vous devez être membre pour ajouter des commentaires.
Devenez membre, ou connectez-vous.
Aucun commentaire n'est disponible pour l'instant